USPTO serial 90818273
3D PREDICT OVARIAN
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- KLEINMAN, CORINNE ANNE
- Law office
- TMO LAW OFFICE 122 - EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with 3D PREDICT OVARIAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Greenville, SC
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KATHRYNN M. LYDDANE
Kathrynn M. Lyddane DORITY & MANNING, P.A.P.O. BOX 1449GREENVILLE, SC 29602-1449UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Assays for clinical or laboratory research purposes, namely, for testing anti-cancer therapies, other than for medical or veterinary use; Assays for use in anti-cancer therapy research; Assays for testing cellular response to anti-cancer therapies, other than for medical or veterinary use; Assay kits comprising cell culture reagents for culturing cells for clinical laboratory or research use | ACTIVE | — |
| 005 | Assay kits comprising clinical medical reagents for culturing cells for clinical medical use | ACTIVE | — |
| 009 | Scientific instruments and apparatus for ex vivo three-dimensional cell culture, namely, bioreactor for cell culturing, for laboratory use; scientific instruments and apparatus for ex vivo microtumor modeling | ACTIVE | — |
| 010 | Medical apparatus, devices, and instruments for the analysis of tumor response to anti-cancer therapies; Kit comprising medical apparatus, devices, and instruments for performing clinical assays of anti-cancer therapies | ACTIVE | — |
| 042 | Medical research services related to predictive tests for patient benefit from anti-cancer drugs or combination of drugs; Pharmaceutical research services, namely, preclinical assessment of pharmaceutical drugs; Scientific and technological services, namely, research in the field of anti-cancer therapies using ex vivo assays; Medical testing services, namely, performing non-clinical assays and testing for medical research purposes in the field of anti-cancer therapies, not for diagnostic or treatment purposes; Providing medical and scientific research information in the field of clinical trials, assays, and assay development, and cancer; Laboratory research in the field of oncology | ACTIVE | — |
| 044 | Medical clinical testing services for diagnostic or treatment purposes, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies; Medical services in the nature of personalized medicine services, namely, conducting predictive patient-specific clinical assays, modeling and assessing response of live cancer cells to investigational and approved cancer therapies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by KIYATEC Inc.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named 3D PREDICT OVARIAN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 20, 2024 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Feb 20, 2024 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Feb 20, 2024 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Jan 10, 2024 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Oct 18, 2023 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Oct 18, 2023 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Oct 18, 2023 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Aug 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 27, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 27, 2023 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Apr 27, 2023 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Apr 27, 2023 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Oct 27, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Oct 27, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Oct 27, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 30, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 28, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 12, 2021 | NWAP | NEW APPLICATION ENTERED | — |